PGF and metastatic colorectal cancer: PGF was reported to be associated with an angiogenesis pathway different from VEGF, and PGF blockade combined with the 5-FU + Folinic acid + Irinotecan (FOLFIRI) regimen improved the survival of patients with metastatic colorectal cancer who had resistance to chemotherapy [47].